1. Home
  2. Labeler Index
  3. Physicians Total Care, Inc.
  4. 54868-6052
  5. Product Images: Sumatriptan

Product Images Sumatriptan

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. Sumatriptan Nasal Spray Sandoz 20 mg label - 20mg package label
  2. Chemical structure - e1539630 59d8 49ed 999e 3c0b4bf056a8 01
  3. Figure 1. Estimated Probability of Achieving Initial Headache Response Within 120 Minutes* - e1539630 59d8 49ed 999e 3c0b4bf056a8 02
  4. Figure 2. The Estimated Probability of Patients Taking a Second Dose or Other Medication for Migraine Over the 24 Hours Following the Initial Dose of Study Treatment* - e1539630 59d8 49ed 999e 3c0b4bf056a8 03

Product Label Images

The following 4 images provide visual information about the product associated with Sumatriptan NDC 54868-6052 by Physicians Total Care, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Sumatriptan Nasal Spray Sandoz 20 mg label - 20mg package label

Sumatriptan Nasal Spray Sandoz 20 mg label - 20mg package label

This information appears to be related to a healthcare product, specifically a medication called "SUNATRIPTRN 204G NAS SPY". It comes in a packaging labeled as "LOT" with a numerical code "0e00", and it has an expiration date of "01/80". The product is distributed by "EL!!;N&ILVOV&L CARE" and has an NDC code of "54868-6052-0". There is an additional numerical code "60520060000" that is not clear what it represents.*

Chemical structure - e1539630 59d8 49ed 999e 3c0b4bf056a8 01

Chemical structure - e1539630 59d8 49ed 999e 3c0b4bf056a8 01

Figure 1. Estimated Probability of Achieving Initial Headache Response Within 120 Minutes* - e1539630 59d8 49ed 999e 3c0b4bf056a8 02

Figure 1. Estimated Probability of Achieving Initial Headache Response Within 120 Minutes* - e1539630 59d8 49ed 999e 3c0b4bf056a8 02

Figure 2. The Estimated Probability of Patients Taking a Second Dose or Other Medication for Migraine Over the 24 Hours Following the Initial Dose of Study Treatment* - e1539630 59d8 49ed 999e 3c0b4bf056a8 03

Figure 2. The Estimated Probability of Patients Taking a Second Dose or Other Medication for Migraine Over the 24 Hours Following the Initial Dose of Study Treatment* - e1539630 59d8 49ed 999e 3c0b4bf056a8 03

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.